BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10822932)

  • 1. Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children.
    Ng SM; Ariffin WA; Lin HP; Chan LL; Chin YM
    J Trop Pediatr; 2000 Apr; 46(2):73-8. PubMed ID: 10822932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age, sex, haemoglobin level, and white cell count at diagnosis are important prognostic factors in children with acute lymphoblastic leukemia treated with BFM-type protocol.
    Ng SM; Lin HP; Ariffin WA; Zainab AK; Lam SK; Chan LL
    J Trop Pediatr; 2000 Dec; 46(6):338-43. PubMed ID: 11191144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather HN; Gaynon PS; Arthur DC; Trigg ME; Tubergen DG; Nachman J; Steinherz PG; Sensel MG; Reaman GH
    Blood; 1997 Jul; 90(1):28-35. PubMed ID: 9207434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood.
    Wiersma SR; Ortega J; Sobel E; Weinberg KI
    N Engl J Med; 1991 Mar; 324(12):800-8. PubMed ID: 1997852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
    Drexler HG; Thiel E; Ludwig WD
    Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.
    Preti HA; Huh YO; O'Brien SM; Andreeff M; Pierce ST; Keating M; Kantarjian HM
    Cancer; 1995 Nov; 76(9):1564-70. PubMed ID: 8635059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of aberrant immunophenotypes in childhood acute lymphoid leukemia.
    Kurec AS; Belair P; Stefanu C; Barrett DM; Dubowy RL; Davey FR
    Cancer; 1991 Jun; 67(12):3081-6. PubMed ID: 2044051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
    Boldt DH; Kopecky KJ; Head D; Gehly G; Radich JP; Appelbaum FR
    Leukemia; 1994 Dec; 8(12):2118-26. PubMed ID: 7807999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
    Hann IM; Richards SM; Eden OB; Hill FG
    Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
    Hsu PN; Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Liang DC; Lin KS
    J Formos Med Assoc; 1991 Mar; 90(3):225-31. PubMed ID: 1677396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.
    Vitale A; Guarini A; Ariola C; Meloni G; Perbellini O; Pizzuti M; De Gregoris C; Mettivier V; Pastorini A; Pizzolo G; Vignetti M; Mandelli F; Foà R
    Haematologica; 2007 Mar; 92(3):342-8. PubMed ID: 17339183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
    Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
    Pui CH; Behm FG; Singh B; Rivera GK; Schell MJ; Roberts WM; Crist WM; Mirro J
    Blood; 1990 Jan; 75(1):198-202. PubMed ID: 2294988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation, hematologic features and treatment outcome of childhood acute lymphoblastic leukemia: a review of 73 cases in Hong Kong.
    Ma SK; Chan GC; Ha SY; Chiu DC; Lau YL; Chan LC
    Hematol Oncol; 1997 Aug; 15(3):141-9. PubMed ID: 9600113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.
    Putti MC; Rondelli R; Cocito MG; Aricó M; Sainati L; Conter V; Guglielmi C; Cantú-Rajnoldi A; Consolini R; Pession A; Zanesco L; Masera G; Biondi A; Basso G
    Blood; 1998 Aug; 92(3):795-801. PubMed ID: 9680347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-lineage acute lymphoblastic leukemia of childhood. An institutional experience.
    Rivera-Luna R; Cardenas-Cardos R; Leal-Leal C; Navarro-Alegría I; Meza-Coria C; Gómez-Martínez R; Vega-Vega L
    Arch Med Res; 1997; 28(2):233-9. PubMed ID: 9204615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotyping pediatric leukemias in Kelantan, Malaysia.
    Menon BS; Dasgupta A; Jackson N
    Pediatr Hematol Oncol; 1998; 15(2):175-8. PubMed ID: 9592844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications.
    Lauria F; Raspadori D; Martinelli G; Rondelli D; Ventura MA; Farabegoli P; Tosi P; Testoni N; Visani G; Zaccaria A
    Br J Haematol; 1994 Jun; 87(2):286-92. PubMed ID: 7947269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.